-
1
-
-
0027948470
-
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus
-
Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW: Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37:1380-1385, 1994
-
(1994)
Arthritis Rheum
, vol.37
, pp. 1380-1385
-
-
Blakemore, A.I.1
Tarlow, J.K.2
Cork, M.J.3
Gordon, C.4
Emery, P.5
Duff, G.W.6
-
2
-
-
0028123647
-
Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist
-
Mansfield JC, Holden H, Tarlow JK, di Giovine FS, McDowell TL, Wilson AG, Holdsworth CD, Duff GW: Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106:637-642, 1994
-
(1994)
Gastroenterology
, vol.106
, pp. 637-642
-
-
Mansfield, J.C.1
Holden, H.2
Tarlow, J.K.3
Di Giovine, F.S.4
McDowell, T.L.5
Wilson, A.G.6
Holdsworth, C.D.7
Duff, G.W.8
-
3
-
-
0030062817
-
Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus
-
Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM, Ward JD, Duff GW: Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97:369-374, 1996
-
(1996)
Hum Genet
, vol.97
, pp. 369-374
-
-
Blakemore, A.I.1
Cox, A.2
Gonzalez, A.M.3
Maskil, J.K.4
Hughes, M.E.5
Wilson, R.M.6
Ward, J.D.7
Duff, G.W.8
-
4
-
-
0033596657
-
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
-
Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC: Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99:861-866, 1999
-
(1999)
Circulation
, vol.99
, pp. 861-866
-
-
Francis, S.E.1
Camp, N.J.2
Dewberry, R.M.3
Gunn, J.4
Syrris, P.5
Carter, N.D.6
Jeffery, S.7
Kaski, J.C.8
Cumberland, D.C.9
Duff, G.W.10
Crossman, D.C.11
-
5
-
-
0035172826
-
A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction
-
Zee RY, Lunze K, Lindpaintner K, Ridker PM: A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction. Thromb Haemost 86:1141-1143, 2001
-
(2001)
Thromb Haemost
, vol.86
, pp. 1141-1143
-
-
Zee, R.Y.1
Lunze, K.2
Lindpaintner, K.3
Ridker, P.M.4
-
6
-
-
0033531644
-
Relationship between fasting plasma glucose and glycosylated hemoglobin: Potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria
-
Davidson MB, Schriger DL, Peters AL, Lorber B: Relationship between fasting plasma glucose and glycosylated hemoglobin: Potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281:1203-1210, 1999
-
(1999)
JAMA
, vol.281
, pp. 1203-1210
-
-
Davidson, M.B.1
Schriger, D.L.2
Peters, A.L.3
Lorber, B.4
-
7
-
-
0031955425
-
Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro
-
Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195-198, 1998
-
(1998)
Scand J Immunol
, vol.47
, pp. 195-198
-
-
Santtila, S.1
Savinainen, K.2
Hurme, M.3
-
8
-
-
0031927564
-
IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes
-
Hurme M, Santtila S: IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28:2598-2602, 1998
-
(1998)
Eur J Immunol
, vol.28
, pp. 2598-2602
-
-
Hurme, M.1
Santtila, S.2
-
9
-
-
0030731621
-
NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
-
Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292, 1997
-
(1997)
Diabetologia
, vol.40
, pp. 1286-1292
-
-
Pickup, J.C.1
Mattock, M.B.2
Chusney, G.D.3
Burt, D.4
-
10
-
-
0036312978
-
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
-
Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51:1596-1600, 2002
-
(2002)
Diabetes
, vol.51
, pp. 1596-1600
-
-
Freeman, D.J.1
Norrie, J.2
Caslake, M.J.3
Gaw, A.4
Ford, I.5
Lowe, G.D.6
O'Reilly, D.S.7
Packard, C.J.8
Sattar, N.9
-
11
-
-
0036230414
-
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study
-
Festa A, D'Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study. Diabetes 51:1131-1137, 2002
-
(2002)
Diabetes
, vol.51
, pp. 1131-1137
-
-
Festa, A.1
D'Agostino R., Jr.2
Tracy, R.P.3
Haffner, S.M.4
-
12
-
-
0034636751
-
Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: The effect of alpha-tocopherol supplementation
-
Devaraj S, Jialal I: Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: The effect of alpha-tocopherol supplementation. Circulation 102:191-196, 2000
-
(2000)
Circulation
, vol.102
, pp. 191-196
-
-
Devaraj, S.1
Jialal, I.2
-
13
-
-
1842334456
-
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
-
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
-
(1997)
Diabetes Care
, vol.20
, pp. 1183-1197
-
-
-
14
-
-
0027212397
-
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
-
Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW: Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403-404, 1993
-
(1993)
Hum Genet
, vol.91
, pp. 403-404
-
-
Tarlow, J.K.1
Blakemore, A.I.2
Lennard, A.3
Solari, R.4
Hughes, H.N.5
Steinkasserer, A.6
Duff, G.W.7
|